Cite

HARVARD Citation

    Hundertmark, M. et al. (2021). Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure. ESC heart failure. pp. 2580-2590. [Online]. 
  
Back to record